Track topics on Twitter Track topics that are important to you
Wednesday, August 2nd 2017 at 8:05pm UTC – Completed enrollment in Northstar-2, Phase 3 study of LentiGlobinTM drug product in patients with transfusion-dependent β-thalassemia (TDT) and non-β0/β0 genotypes – – Presented updated clinical results from studies in relapsed/refractory multiple myeloma, TDT and severe sickle cell disease (SCD) at American Society of Clinical Oncology (ASCO) Annual …
Cet article bluebird bio Reports Second Quarter 2017 Financial Results and Recent
Operational Progress est apparu en premier sur EEI-BIOTECHFINANCES.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...